Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00775671 · ClinicalTrials.gov registry record · Phase 4
Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome
A Phase 4 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT00775671 is a Phase 4 study that has completed, run by Vanderbilt University. The registered enrollment target is 46 participants.
The verdict
NCT00775671, a Phase 4 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
Test the hypothesis that nebivolol treatment improves fibrinolytic balance and insulin sensitivity compared to metoprolol treatment in individuals with metabolic syndrome.
Interventions
- DRUG placebo
- DRUG Nebivolol
- DRUG Metoprolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00775671
The ClinicalTrials.gov registry entry for NCT00775671 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00775671 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00775671 about?
NCT00775671 is a clinical study titled "Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome". Test the hypothesis that nebivolol treatment improves fibrinolytic balance and insulin sensitivity compared to metoprolol treatment in individuals with metabolic syndrome.
What is the current status of trial NCT00775671?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2008-10. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00775671?
The interventions under investigation include: placebo (DRUG), Nebivolol (DRUG), Metoprolol (DRUG).
Who is sponsoring clinical trial NCT00775671?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.